Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal
- PMID: 28278495
- PMCID: PMC5588418
- DOI: 10.1159/000468988
Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal
Abstract
The gastrointestinal tract digests and absorbs dietary nutrients, protects the body against physical and chemical damage from contents in its lumen, provides immunity against external antigens, and keeps an optimum environment for the gut microbiota. These functions cannot be performed normally in several diseases of which the following are discussed here: irritable bowel syndrome and inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Because these diseases are associated with oxidative stress, a host of antioxidant supplements are used for maintenance and recovery of the gut functions. However, the benefits of these supplements have not been established. The available 80 human trials were rated for levels of confidence and for benefits of the antioxidant supplements. For Crohn's disease, the supplements for which clear benefits occurred in at least 2 studies were allopurinol, Boswellia serrata (frankincense or shallaki), Artemesia species (wormwood), Tripterygium wilfordii (léi gōng téng), and omega-3 fatty acids. Similar beneficial supplements for ulcerative colitis were allopurinol, Matricaria chamomilla (chamomile), Curcuma longa (curcumin in turmeric), and omega-3 fatty acids. There was also a clear benefit for ulcerative colitis in 2 studies where a multiherbal Chinese medicine preparation and an Ayurvedic medicine preparation were used. For irritable bowel syndrome, there was only a marginal benefit of some of the antioxidant supplements. Thus, some antioxidant supplements may be beneficial at certain stages of specific diseases. This is consistent with the current concept that antioxidants act by inhibiting oxidative stress pathways in a tissue- and environment-specific manner and not by simply acting as scavengers.
Keywords: Allopurinol; Ayurveda; Boswellia; Chinese medicine; Crohn’s disease; Curcumin; Inflammatory bowel disease; Irritable bowel syndrome; Omega-3 fatty acids; Ulcerative colitis.
© 2017 S. Karger AG, Basel.
Comment in
-
Antioxidant Supplements and Gastrointestinal Diseases.Med Princ Pract. 2017;26(4):397. doi: 10.1159/000477304. Epub 2017 May 7. Med Princ Pract. 2017. PMID: 28535534 Free PMC article. No abstract available.
-
Thiol Levels and Gastrointestinal Diseases.Med Princ Pract. 2017;26(4):398. doi: 10.1159/000477684. Epub 2017 Jul 15. Med Princ Pract. 2017. PMID: 28715815 Free PMC article. No abstract available.
References
-
- Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med. 2002;5:37–45. - PubMed
-
- Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. - PubMed
-
- Loftus EV., Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517. - PubMed
-
- Lunney PC, Kariyawasam VC, Wang RR, et al. Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2015;42:61–70. - PubMed
-
- Kamiya T. The overlap in the genetic pathogenesis of ulcerative colitis and irritable bowel syndrome. Dig Dis Sci. 2013;58:3379–3381. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
